LAUSR

OBJECTIVE To evaluate the effect of probiotics on gingival inflammation and oral microbiota in patients suffering from plaque-induced gingivitis. METHODS PubMed, Cochrane Central Register of Controlled Trials (CENTRAL) and EMBASE were electronically searched until December 2020. The quality of included studies was assessed with the Cochrane Collaboration's Risk of Bias tool. The differences were expressed as weighted mean differences (WMD) and 95% of confidence interval (95% CI). I2 test was performed to evaluate the heterogeneity of the studies. All analyses were performed using Review Manager (version 5.3). RESULTS Eleven randomized and controlled trials were included, enrolling 554 patients. All comparisons displayed that oral probiotics had no significant improvement in the Gingival index (GI), Plaque index (PI), and Bleeding on probing (BOP) of patients with plaque-induced gingivitis. In terms of microecology, no significant difference in the volumes of Gingival crevicular fluid (GCF), the concentration of IL-1β and the counts of Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), Prevotella intermedia (Pi) and Fusobacterium nucleatum (Fn) were found between the probiotic group and the placebo group. CONCLUSION There exists no clear evidence that oral probiotics has positive effect on the gingival inflammation and oral microecological environment of patients with plaque-induced gingivitis.